Clinical use of the volatile anaesthetic sevoflurane, whose contribution to the greenhouse effect and thus to the climate crisis is as a threat to global human health
Conditions
Interventions
Group 1: This is a retrospective study without any intervention.
Sponsors
Klinik für Anästhesiologie der Universitätsmedizin Göttingen
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: This is a retrospective observational study in which clinical data were collected during routine clinical care. Accordingly, there was no recruitment as in other clinical trials.
Exclusion criteria
Exclusion criteria: This is a retrospective observational study in which clinical data were collected during routine clinical care. Accordingly, there was no recruitment as in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1) How did the recommendations for the use of sevoflurane in our department change over the past 10 years? For this, the department's internal guideline documents from before 2015 are compared with the current guidelines. (2) How did the consumption of sevoflurane in our department change over the past 10 years? For this, the order data of the most commonly used anaesthetic drugs from our hospital pharmacy are analysed. (3) How is sevoflurane currently used in our department? For this, all general anaesthesia cases in our department in January and February 2026 are examined. | — |
Countries
Germany
Contacts
Public ContactFrederic Michaelsen
Universitätsmedizin Göttingen - Klinik für Anästhesiologie
Outcome results
None listed